Loading stock data…
$0.80-0.03 (-3.56%)
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. in the Healthcare sector is trading at $0.80 with a market capitalization of $982,979. The stock is currently near its 52-week low of $0.76, remaining 59.2% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.35M↓ | -$1.94M↓ | -$1.46M↑ | -$1.62M↑ | -$1.99M |
| Net Income | -$2.32M↓ | -$1.92M↓ | -$1.43M↑ | -$1.60M↑ | -$1.96M |
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarke...